Cargando…
Cerebrospinal Fluid Homer-3 Autoantibodies in a Patient with Amnestic Mild Cognitive Impairment
(1) Background: Homer-3 antibodies are associated with cerebellar disease ranging from subacute degeneration to cerebellitis. However, cognitive impairment associated with Homer-3 autoantibodies has not been reported until now. (2) Methods: in retrospect, we systematically studied clinical, cranial...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856294/ https://www.ncbi.nlm.nih.gov/pubmed/36672107 http://dx.doi.org/10.3390/brainsci13010125 |
_version_ | 1784873585399037952 |
---|---|
author | Hansen, Niels Radenbach, Katrin Rentzsch, Kristin Fox, Janosch Wiltfang, Jens Bartels, Claudia |
author_facet | Hansen, Niels Radenbach, Katrin Rentzsch, Kristin Fox, Janosch Wiltfang, Jens Bartels, Claudia |
author_sort | Hansen, Niels |
collection | PubMed |
description | (1) Background: Homer-3 antibodies are associated with cerebellar disease ranging from subacute degeneration to cerebellitis. However, cognitive impairment associated with Homer-3 autoantibodies has not been reported until now. (2) Methods: in retrospect, we systematically studied clinical, cranial magnetic resonance imaging (cMRI), electroencephalography (EEG) and lumbar puncture data, including neural autoantibodies of a clinical case. (3) Results: we describe the case of a 56-year-old woman presenting with amnestic mild cognitive impairment in association with serum and CSF detection of Homer-3 autoantibodies and a depressive syndrome. cMRI revealed cerebellar atrophy. CSF analysis showed elevated ptau181 protein. Applying the criteria for an autoimmune psychiatric syndrome revealed a plausible autoimmune basis for the mild cognitive impairment. (4) Discussions: our case report demonstrates an amnestic mild cognitive impairment and depressive symptoms associated with Homer-3 autoantibodies as a novel feature of Homer-3 antibody-related disease. We also propose that cognitive dysfunction might result from impaired AMPAR signaling in the hippocampus induced by Homer-3 antibodies, which will have to be verified in further research. |
format | Online Article Text |
id | pubmed-9856294 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98562942023-01-21 Cerebrospinal Fluid Homer-3 Autoantibodies in a Patient with Amnestic Mild Cognitive Impairment Hansen, Niels Radenbach, Katrin Rentzsch, Kristin Fox, Janosch Wiltfang, Jens Bartels, Claudia Brain Sci Case Report (1) Background: Homer-3 antibodies are associated with cerebellar disease ranging from subacute degeneration to cerebellitis. However, cognitive impairment associated with Homer-3 autoantibodies has not been reported until now. (2) Methods: in retrospect, we systematically studied clinical, cranial magnetic resonance imaging (cMRI), electroencephalography (EEG) and lumbar puncture data, including neural autoantibodies of a clinical case. (3) Results: we describe the case of a 56-year-old woman presenting with amnestic mild cognitive impairment in association with serum and CSF detection of Homer-3 autoantibodies and a depressive syndrome. cMRI revealed cerebellar atrophy. CSF analysis showed elevated ptau181 protein. Applying the criteria for an autoimmune psychiatric syndrome revealed a plausible autoimmune basis for the mild cognitive impairment. (4) Discussions: our case report demonstrates an amnestic mild cognitive impairment and depressive symptoms associated with Homer-3 autoantibodies as a novel feature of Homer-3 antibody-related disease. We also propose that cognitive dysfunction might result from impaired AMPAR signaling in the hippocampus induced by Homer-3 antibodies, which will have to be verified in further research. MDPI 2023-01-11 /pmc/articles/PMC9856294/ /pubmed/36672107 http://dx.doi.org/10.3390/brainsci13010125 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Hansen, Niels Radenbach, Katrin Rentzsch, Kristin Fox, Janosch Wiltfang, Jens Bartels, Claudia Cerebrospinal Fluid Homer-3 Autoantibodies in a Patient with Amnestic Mild Cognitive Impairment |
title | Cerebrospinal Fluid Homer-3 Autoantibodies in a Patient with Amnestic Mild Cognitive Impairment |
title_full | Cerebrospinal Fluid Homer-3 Autoantibodies in a Patient with Amnestic Mild Cognitive Impairment |
title_fullStr | Cerebrospinal Fluid Homer-3 Autoantibodies in a Patient with Amnestic Mild Cognitive Impairment |
title_full_unstemmed | Cerebrospinal Fluid Homer-3 Autoantibodies in a Patient with Amnestic Mild Cognitive Impairment |
title_short | Cerebrospinal Fluid Homer-3 Autoantibodies in a Patient with Amnestic Mild Cognitive Impairment |
title_sort | cerebrospinal fluid homer-3 autoantibodies in a patient with amnestic mild cognitive impairment |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856294/ https://www.ncbi.nlm.nih.gov/pubmed/36672107 http://dx.doi.org/10.3390/brainsci13010125 |
work_keys_str_mv | AT hansenniels cerebrospinalfluidhomer3autoantibodiesinapatientwithamnesticmildcognitiveimpairment AT radenbachkatrin cerebrospinalfluidhomer3autoantibodiesinapatientwithamnesticmildcognitiveimpairment AT rentzschkristin cerebrospinalfluidhomer3autoantibodiesinapatientwithamnesticmildcognitiveimpairment AT foxjanosch cerebrospinalfluidhomer3autoantibodiesinapatientwithamnesticmildcognitiveimpairment AT wiltfangjens cerebrospinalfluidhomer3autoantibodiesinapatientwithamnesticmildcognitiveimpairment AT bartelsclaudia cerebrospinalfluidhomer3autoantibodiesinapatientwithamnesticmildcognitiveimpairment |